Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles


SEVAL M. M., ÖZMEN B., Atabekoglu C., ŞÜKÜR Y. E., Simsir C., Kan O., ...Daha Fazla

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.42, sa.9, ss.1146-1151, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 9
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1111/jog.13021
  • Dergi Adı: JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1146-1151
  • Anahtar Kelimeler: clinical, female, assisted reproductive technology, infertility, FOLLICLE-STIMULATING-HORMONE, FINAL OOCYTE MATURATION, GNRH AGONIST, ESTRADIOL, COMBINATION, RESPONDERS, PREVENTION, INDUCTION, OVULATION, HCG
  • Ankara Üniversitesi Adresli: Evet

Özet

AimThe aim of this study was to evaluate whether dual trigger with leuprolide acetate plus recombinant human chorionic gonadotropin (hCG) improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.